Cargando…

Current Trends in Cancer Immunotherapy

The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this affliction. It has also become a serious challenge for scientists and clinicians who have needed to invent new ways of overcoming the proble...

Descripción completa

Detalles Bibliográficos
Autores principales: Filin, Ivan Y., Solovyeva, Valeriya V., Kitaeva, Kristina V., Rutland, Catrin S., Rizvanov, Albert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766207/
https://www.ncbi.nlm.nih.gov/pubmed/33348704
http://dx.doi.org/10.3390/biomedicines8120621
_version_ 1783628663616438272
author Filin, Ivan Y.
Solovyeva, Valeriya V.
Kitaeva, Kristina V.
Rutland, Catrin S.
Rizvanov, Albert A.
author_facet Filin, Ivan Y.
Solovyeva, Valeriya V.
Kitaeva, Kristina V.
Rutland, Catrin S.
Rizvanov, Albert A.
author_sort Filin, Ivan Y.
collection PubMed
description The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this affliction. It has also become a serious challenge for scientists and clinicians who have needed to invent new ways of overcoming the problems encountered during treatments, and have also made important discoveries pertaining to fundamental issues relating to the emergence and development of malignant neoplasms. Understanding the basics of the human immune system interactions with tumor cells has enabled new cancer immunotherapy strategies. The initial successes observed in immunotherapy led to new methods of treating cancer and attracted the attention of the scientific and clinical communities due to the prospects of these methods. Nevertheless, there are still many problems that prevent immunotherapy from calling itself an effective drug in the fight against malignant neoplasms. This review examines the current state of affairs for each immunotherapy method, the effectiveness of the strategies under study, as well as possible ways to overcome the problems that have arisen and increase their therapeutic potentials.
format Online
Article
Text
id pubmed-7766207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77662072020-12-28 Current Trends in Cancer Immunotherapy Filin, Ivan Y. Solovyeva, Valeriya V. Kitaeva, Kristina V. Rutland, Catrin S. Rizvanov, Albert A. Biomedicines Review The search for an effective drug to treat oncological diseases, which have become the main scourge of mankind, has generated a lot of methods for studying this affliction. It has also become a serious challenge for scientists and clinicians who have needed to invent new ways of overcoming the problems encountered during treatments, and have also made important discoveries pertaining to fundamental issues relating to the emergence and development of malignant neoplasms. Understanding the basics of the human immune system interactions with tumor cells has enabled new cancer immunotherapy strategies. The initial successes observed in immunotherapy led to new methods of treating cancer and attracted the attention of the scientific and clinical communities due to the prospects of these methods. Nevertheless, there are still many problems that prevent immunotherapy from calling itself an effective drug in the fight against malignant neoplasms. This review examines the current state of affairs for each immunotherapy method, the effectiveness of the strategies under study, as well as possible ways to overcome the problems that have arisen and increase their therapeutic potentials. MDPI 2020-12-17 /pmc/articles/PMC7766207/ /pubmed/33348704 http://dx.doi.org/10.3390/biomedicines8120621 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Filin, Ivan Y.
Solovyeva, Valeriya V.
Kitaeva, Kristina V.
Rutland, Catrin S.
Rizvanov, Albert A.
Current Trends in Cancer Immunotherapy
title Current Trends in Cancer Immunotherapy
title_full Current Trends in Cancer Immunotherapy
title_fullStr Current Trends in Cancer Immunotherapy
title_full_unstemmed Current Trends in Cancer Immunotherapy
title_short Current Trends in Cancer Immunotherapy
title_sort current trends in cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766207/
https://www.ncbi.nlm.nih.gov/pubmed/33348704
http://dx.doi.org/10.3390/biomedicines8120621
work_keys_str_mv AT filinivany currenttrendsincancerimmunotherapy
AT solovyevavaleriyav currenttrendsincancerimmunotherapy
AT kitaevakristinav currenttrendsincancerimmunotherapy
AT rutlandcatrins currenttrendsincancerimmunotherapy
AT rizvanovalberta currenttrendsincancerimmunotherapy